1. Bhatia, R, Hill, MD, Shobha, N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke. Stroke 2010; 41: 2254–2258.
Google Scholar | Crossref | Medline | ISI2. Hirano, T, Sasaki, M, Mori, E, et al. Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients. Stroke 2010; 41: 2828–2833.
Google Scholar | Crossref | Medline3. Coutts, SB, Berge, E, Campbell, BC, et al. Tenecteplase for the treatment of acute ischemic stroke: a review of completed and ongoing randomized controlled trials. International Journal of Stroke 2018; 13: 885–892.
Google Scholar | SAGE Journals | ISI4. Vishnu, VY, Padma Srivastava, MV. Innovations in acute stroke reperfusion strategies. Annals of Indian Academy of Neurology 2019; 22: 6–12.
Google Scholar | Crossref | Medline5. Campbell, BCV, Mitchell, PJ, Churilov, L, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. New England Journal of Medicine 2018; 378: 1573–1582.
Google Scholar | Crossref | Medline6. Goyal, M, Fargen, KM, Turk, AS, et al. 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. Journal of NeuroInterventional Surgery 2014; 6: 83–86.
Google Scholar | Crossref | Medline | ISI7. Wahlgren, N, Ahmed, N, Dávalos, A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. The Lancet 2007; 369: 275–282.
Google Scholar | Crossref | Medline | ISI8. Persons, M, Spratt, N, Bivard, A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012; 366: 1099–1107.
Google Scholar | Crossref | Medline9. Haley, EC, Thompson, JLP, Grotta, JC, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke. Stroke 2010; 41: 707–711.
Google Scholar | Crossref | Medline | ISI10. Campbell, BCV, Mitchell, PJ, Churilov, L, et al. Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke. JAMA 2020; 323: 1257–1265.
Google Scholar | Crossref | Medline11. Zhong, CS, Beharry, J, Salazar, D, et al. Routine use of tenecteplase for thrombolysis in acute ischemic stroke. Stroke 2021; 52: 1087–1090.
Google Scholar | Crossref | Medline12. Anderson, CS, Robinson, T, Lindley, RI, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. New England Journal of Medicine 2016; 374: 2313–2323.
Google Scholar | Crossref | Medline | ISI13. Powers, WJ, Rabinstein, AA, Ackerson, T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2019; 50: e344–e418.
Google Scholar | Crossref | Medline14. https://informme.org.au/en/Guidelines/Clinical-Guidelines-for-Stroke-Management
Google Scholar